
BL-6020/979 (SNT207979) is an orally available, селективный, мощный MC4R антагонист с IC50 of 19 nM; weakly binds to MC-3 and MC-5 receptors с IC50 of 2.7 uM and 0.89 uM, respectively, >10,000-fold selectivity over MC-1R; demonstrates in animal models and presents a promising candidate suitable for further development towards a first-in-class treatment option for cachexia.
BL-6020/979 (SNT207979) is an orally available, selective, potent MC4R antagonist with IC50 of 19 nM; weakly binds to MC-3 and MC-5 receptors with IC50 of 2.7 uM and 0.89 uM, respectively, >10,000-fold selectivity over MC-1R; demonstrates in animal models and presents a promising candidate suitable for further development towards a first-in-class treatment option for cachexia.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.